Literature DB >> 10571052

Subcellular trafficking abnormalities of a prion protein with a disrupted disulfide loop.

A Yanai1, Z Meiner, I Gahali, R Gabizon, A Taraboulos.   

Abstract

The single disulfide loop (Cys178-Cys213) of the prion protein (PrP) may stabilize the conformation of this protein by bridging the C-terminal alpha-helices. The substitution mutant Cys178Ala fails to form the prion isoform PrPSc when expressed in scrapie-infected neuroblastoma ScN2a cells (Muramoto et al., Proc. Natl. Acad. Sci. USA 93, 15457-15462). To investigate the reasons for this failure, we introduced the C178A substitution in the full length mouse PrP gene as well as in its N-terminally truncated delta23-88 version. The resulting mutants (C178A and deltaC178A, respectively) were transiently expressed in N2a and CHO cells. Wild-type PrP, wild-type delta23-88 and the point mutant E199K served as controls in these experiments. Compared to the wild-type controls, the C178A mutants were markedly resistant to proteolysis and they were also vastly insoluble in sarcosyl. Studying the metabolic fate of the C178A mutants, we found that in contrast to control PrP molecules, these mutants (i) remained sensitive to the diagnostic endoglycosidase EndoH, (ii) failed to reach the cell surface and (iii) congregated in large juxtanuclear spots. We surmise that these severe trafficking abnormalities may contribute both to the spontaneous aggregation of the C178A mutants and to their reported inability to form PrP(Sc).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571052     DOI: 10.1016/s0014-5793(99)01316-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  The role of dimerization in prion replication.

Authors:  Peter Tompa; Gábor E Tusnády; Peter Friedrich; István Simon
Journal:  Biophys J       Date:  2002-04       Impact factor: 4.033

2.  ERp57 as a novel cellular factor controlling prion protein biosynthesis: Therapeutic potential of protein disulfide isomerases.

Authors:  Martin Sepulveda; Pablo Rozas; Claudio Hetz; Danilo B Medinas
Journal:  Prion       Date:  2016       Impact factor: 3.931

3.  The Protein-disulfide Isomerase ERp57 Regulates the Steady-state Levels of the Prion Protein.

Authors:  Mauricio Torres; Danilo B Medinas; José Manuel Matamala; Ute Woehlbier; Víctor Hugo Cornejo; Tatiana Solda; Catherine Andreu; Pablo Rozas; Soledad Matus; Natalia Muñoz; Carmen Vergara; Luis Cartier; Claudio Soto; Maurizio Molinari; Claudio Hetz
Journal:  J Biol Chem       Date:  2015-07-13       Impact factor: 5.157

Review 4.  Lysosomal Quality Control in Prion Diseases.

Authors:  Priyanka Majumder; Oishee Chakrabarti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

5.  Failure of prion protein oxidative folding guides the formation of toxic transmembrane forms.

Authors:  Silvia Lisa; Beatriz Domingo; Javier Martínez; Sabine Gilch; Juan F Llopis; Hermann M Schätzl; María Gasset
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

6.  Retrotranslocation of prion proteins from the endoplasmic reticulum by preventing GPI signal transamidation.

Authors:  Aarthi Ashok; Ramanujan S Hegde
Journal:  Mol Biol Cell       Date:  2008-05-28       Impact factor: 4.138

7.  In vitro amplification of misfolded prion protein using lysate of cultured cells.

Authors:  Charles E Mays; Jihyun Yeom; Hae-Eun Kang; Jifeng Bian; Vadim Khaychuk; Younghwan Kim; Jason C Bartz; Glenn C Telling; Chongsuk Ryou
Journal:  PLoS One       Date:  2011-03-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.